Neurizon Therapeutics (FRA:ECQ0) Days Inventory : 0.00 (As of Dec. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Neurizon Therapeutics Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Neurizon Therapeutics's Average Total Inventories for the six months ended in Dec. 2024 was €0.00 Mil. Neurizon Therapeutics's Cost of Goods Sold for the six months ended in Dec. 2024 was €0.00 Mil.

The historical rank and industry rank for Neurizon Therapeutics's Days Inventory or its related term are showing as below:

FRA:ECQ0' s Days Inventory Range Over the Past 10 Years
Min: 84.25 Med: 84.25 Max: 84.25
Current: 84.25

During the past 6 years, Neurizon Therapeutics's highest Days Inventory was 84.25. The lowest was 84.25. And the median was 84.25.

FRA:ECQ0's Days Inventory is ranked better than
75.97% of 645 companies
in the Biotechnology industry
Industry Median: 178.46 vs FRA:ECQ0: 84.25

Neurizon Therapeutics's Days Inventory stayed the same from Dec. 2023 (0.00) to Dec. 2024 (0.00).

Warning Sign:

If a company builds up inventory, it may mean it is having difficulties selling its goods.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Neurizon Therapeutics Days Inventory Historical Data

The historical data trend for Neurizon Therapeutics's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurizon Therapeutics Days Inventory Chart

Neurizon Therapeutics Annual Data

Trend

Jun01

Jun02

Jun03

Jun04

Jun05

Jun24

Days Inventory

Get a 7-Day Free Trial

84.33

Neurizon Therapeutics Semi-Annual Data
	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Jun24	Dec24
Days Inventory	Get a 7-Day Free Trial															1,110.99	1,126.26	-	-	-

Competitive Comparison of Neurizon Therapeutics's Days Inventory

For the Biotechnology subindustry, Neurizon Therapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neurizon Therapeutics's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neurizon Therapeutics's Days Inventory distribution charts can be found below:

* The bar in red indicates where Neurizon Therapeutics's Days Inventory falls into.

Save Embed

;

Save Embed

;

Neurizon Therapeutics Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Neurizon Therapeutics's Days Inventory for the fiscal year that ended in Jun. 2005 is calculated as

	Days Inventory (A: Jun. 2005 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Jun. 2004 )	+	Total Inventories (A: Jun. 2005 ))	/	count )	/	Cost of Goods Sold (A: Jun. 2005 )	*	Days in Period
=	( (0	+	0.192)	/	1 )	/	0.831	*	365
=	0.192					/	0.831	*	365
=	84.33

Neurizon Therapeutics's Days Inventory for the quarter that ended in Dec. 2024 is calculated as:

	Days Inventory (Q: Dec. 2024 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Jun. 2024 )	+	Total Inventories (Q: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 2
=	0					/	0	*	365 / 2
=	N/A

Neurizon Therapeutics (FRA:ECQ0) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Neurizon Therapeutics's Inventory Turnover for the six months ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0
	=

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Neurizon Therapeutics's Inventory to Revenue for the six months ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	0
	=

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Neurizon Therapeutics Days Inventory Related Terms

Thank you for viewing the detailed overview of Neurizon Therapeutics's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurizon Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neurizon Therapeutics Ltd (FRA:ECQ0) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

NUZ:Australia

Address

96-100 Albert Road, Level 4, South Melbourne, Melbourne, VIC, AUS, 3205

Website

https://www.neurizon.com

Neurizon Therapeutics Ltd is a clinical-stage biotech company that develops drug discovery intellectual property for the treatment of different types of neurodegenerative diseases. Its product pipeline is NUZ-001 (S-Monepantel).

Neurizon Therapeutics Headlines

No Headlines